@article{Antonelli_M-2023_151344,
title = {SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study},
author = {Antonelli, M. and Penfold, R. and Canas, L. and Sudre, C. and Rjoob, K. and Murray, B. and Molteni, E. and Kerfoot, E. and Cheetham, N. and Pujol, J. and Polidori, L. and May, A. and Wolf, J. and Modat, M. and Spector, T. and Hammers, A. and Ourselin, S. and Steves, C.},
month = {sep},
year = {2023},
abstract = {BACKGROUND: Booster COVID-19 vaccines have shown efficacy in clinical trials and effectiveness in real-world data against symptomatic and severe illness. However, some people still become infected with SARS-CoV-2 following a third (booster) vaccination. This study describes the characteristics of SARS-CoV-2 illness following a third vaccination and assesses the risk of progression to symptomatic disease in SARS-CoV-2 infected individuals with time since vaccination.},
pages = {506-515},
volume = {87},
issue = {6},
journal = {Journal of Infection},
publisher = {Elsevier},
url = {https://doi.org/10.1016/j.jinf.2023.08.009},
}
